Skip to content

Immunopharmacological design of a multi-epitope vaccine targeting hepatitis C virus genotype 3a.

Oct 2026 · Naunyn-Schmiedeberg's Archives of Pharmacology · 0 citations · 57 references
Medicine

TL;DR

Results indicate that multiple-epitope vaccine constructs have strong binding properties and are good candidates for developing a vaccine against HCV3a.

View source

Similar papers

Open access Oct 2026

Designing a multi-epitope vaccine against La Crosse virus using immunoinformatics approach

Overall, the proposed vaccine candidate V1 demonstrates strong immunogenic potential and structural stability, warranting further experimental validation for potential clinical application.

Md. Shamiron Hasnat, Ahsanul Siddique Saim, Mst. Farhana Akter Sarmin et al. · 0 citations
Open access Sep 2026

Immunoinformatics-driven design and in silico characterization of a multiepitope vaccine targeting the hepatitis C virus core protein.

The construct is identified as a promising HCV vaccine candidate that now warrants experimental validation and normal mode analysis and molecular dynamics simulations were performed to assess its stability.

Mohammad-Matin Karbalaee-Alinazari, Ava Hashempour, Ali Honari Jahromi et al. · 0 citations
Open access Sep 2026

Immunoinformatics-based design of a multi-epitope mRNA vaccine candidate targeting the major human-infecting hepatitis E virus genotypes 1–4

Background Hepatitis E virus (HEV) is one of the leading causes of acute and chronic hepatitis among humans across the globe and is linked to severe diseases in immunocompromised individuals and pregnant women. Despite its substantial global burden, only one vaccine is licensed (in China and Pakistan), limiting its glo...

Maham Mehrangaze Khonza, Zain Saeed, Zohra Jabeen et al. · 0 citations
Open access Aug 2026

Leveraging immunoinformatic techniques for the development of a multi-epitope subunit vaccine targeting virulence-associated proteins of Mycobacterium tuberculosis

A multi-epitope subunit vaccine (MESV) candidate using immunoinformatic approaches that targets five virulence-associated proteins and may elicit potent humoral and cellular immune responses against M. tuberculosis are viable options warranting further experimental validation.

Swagat Ranjan Maharana, S. Khan, Kiran Mahapatra et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.